22 Results for "

bifidobacterium

" in MedChemExpress (MCE) Product Catalog:
Products (22)

22 Results for "bifidobacterium" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-41324
CAS No.: 911-40-0
7-keto-Deoxycholic acid is a metabolite of bile acids in Clostridium absonum. 7-keto-Deoxycholic acid is also converted from Lactobacillus and Bifidobacterium with specific condition .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-137335
CAS No.: 157574-76-0
Purity:  ≥98.0%
Target:  

Bacterial VEGFR Akt ERK

Research Areas:  

Infection Inflammation/Immunology

6'-Sialyllactose sodium promotes the growth of beneficial bacteria (such as Bifidobacterium and lactobacillus) and inhibits the proliferation of harmful bacteria. 6'-Sialyllactose sodium exhibits anti-inflammatory and anti-angiogenic activities. 6'-Sialyllactose sodium promotes the muscle health .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N10521
CAS No.: 35890-39-2
6'-Sialyllactose promotes the growth of beneficial bacteria (such as Bifidobacterium and lactobacillus) and inhibits the proliferation of harmful bacteria. 6'-Sialyllactose exhibits anti-inflammatory and anti-angiogenic activities. 6'-Sialyllactose promotes the muscle health .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113133
CAS No.: 2140-29-6
Purity:  99.76%
Kojibiose, an orally active prebiotic disaccharide, can specifically inhibit the activity of α-glucosidase I. kojibiose is a proliferation factor for Bifidobacterium, lactic acid bacteria, and eubacteria. kojibiose is a low-calorie sweetener capable of increasing the absorption of iron. Kojibiose exhibits antitoxic activity. Kojibiose reduces hepatic expression of inflammatory markers in vivo .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-120536
CAS No.: 13080-21-2
Purity:  ≥98.0%
Target:  

Bacterial

Research Areas:  

Infection

HPi1 is a potent, selective and orally active antimicrobial against Helicobacter pylori with an IC50 of 0.24 μM and an MIC of 0.08-0.16 μg/mL. HPi1 is inactive against other bacteria, including the gut commensals Lactobacillus casei, Lactobacillus reuteri, and Bifidobacterium longum .
loading...
    loading...
Cat. No.: HY-P3752
CAS No.: 92327-84-9
Synonyms: H-Gly-Ala-Tyr-OH
Research Areas:  

Others

Gly-Ala-Tyr (H-Gly-Ala-Tyr-OH) is a tripeptide substrate composed of L-glycine, alanine, and L-tyrosine joined in sequence by peptide linkages. Gly-Ala-Tyr can be hydrolyzed at both extracellular and intracellular levels by Streptococcus thermophilus, Lactobacillus delbrueckii ssp. bulgaricus, Lactobacillus acidophilus, and Bifidobacterium spp. Ala-Gly-Tyr is functionally related to L-alanine, glycine and L-tyrosine. .
loading...
    loading...
Cat. No.: HY-132177C
CAS No.: 9037-65-4
Target:  

Glycosidase

Research Areas:  

Metabolic Disease

α1-3,4 Fucosidase, Bifidobacterium bifidum is a broad specificity exoglycosidase that catalyzes the hydrolysis of terminal, non-reducing α1-3 and α1-4 linked fucose residues from oligosaccharides and glycoproteins .
loading...
    loading...
Cat. No.: HY-132177A
CAS No.: 9037-65-4
Target:  

Glycosidase

Research Areas:  

Metabolic Disease

α1-2 Fucosidase (EC 3.2.1.51) is a highly specific exoglycosidase that catalyzes the hydrolysis of linear α1-2 linked fucose residues from oligosaccharides .
loading...
    loading...
Cat. No.: HY-P2988A
CAS No.: 9001-67-6
Target:  

Glycosidase

Research Areas:  

Metabolic Disease

α2-3,6 Neuraminidase, Bifidobacterium infantis is a highly specific exoglycosidase that catalyzes the hydrolysis of non-reducing terminal α2-3 and α2-6 unbranched sialic acid residues from complex carbohydrates and glycoproteins. α2-3,6 Neuraminidase does not exhibit activity on α2-8 or branched sialic acids .
loading...
    loading...
Cat. No.: HY-W007708
CAS No.: 4412-91-3
Category:  

Natural Products 500 - Internal Server Error | MedChemExpress

Oops!

Sorry, Something went wrong on our server.
Our team has been notified and is working to fix the issue.